 Anthraquinones
"Anthraquinones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds based on ANTHRACENES which contains two KETONES in any position. Substitutions can be in any position except on the ketone groups.
| Descriptor ID |
D000880
|
| MeSH Number(s) |
D02.455.426.559.847.117.159 D02.806.100 D04.615.117.159
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Anthraquinones".
Below are MeSH descriptors whose meaning is more specific than "Anthraquinones".
This graph shows the total number of publications written about "Anthraquinones" by people in this website by year, and whether "Anthraquinones" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 1 | 0 | 1 | | 1984 | 1 | 0 | 1 | | 2001 | 1 | 1 | 2 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2014 | 0 | 1 | 1 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anthraquinones" by people in Profiles.
-
Flynn TM, Antonopoulos DA, Skinner KA, Brulc JM, Johnston E, Boyanov MI, Kwon MJ, Kemner KM, O'Loughlin EJ. Biogeochemical dynamics and microbial community development under sulfate- and iron-reducing conditions based on electron shuttle amendment. PLoS One. 2021; 16(5):e0251883.
-
Huang WH, Zhang QW, Yuan CS, Wang CZ, Li SP, Zhou HH. Chemical constituents of the plants from the genus Oplopanax. Chem Biodivers. 2014 Feb; 11(2):181-96.
-
Koshizuka Y, Yamada T, Hoshi K, Ogasawara T, Chung UI, Kawano H, Nakamura Y, Nakamura K, Ikegawa S, Kawaguchi H. Cystatin 10, a novel chondrocyte-specific protein, may promote the last steps of the chondrocyte differentiation pathway. J Biol Chem. 2003 Nov 28; 278(48):48259-66.
-
Goh BC, Vokes EE, Joshi A, Ratain MJ. Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumours. Br J Cancer. 2002 Feb 12; 86(4):534-9.
-
Joshi AS, Pieniaszek HJ, Vokes EE, Vogelzang NJ, Davidson AF, Richards LE, Chai MF, Finizio M, Ratain MJ. Elimination pathways of [14C]losoxantrone in four cancer patients. Drug Metab Dispos. 2001 Feb; 29(2):96-9.
-
Balint E, Szabo P, Marshall CF, Sprague SM. Glucose-induced inhibition of in vitro bone mineralization. Bone. 2001 Jan; 28(1):21-8.
-
Levin M, Pandya KJ, Khandekar JD, Horton J, Glick JH, Bennett JM, Muggia FM, Falkson G. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study. Cancer Treat Rep. 1984 Dec; 68(12):1511-2.
-
Gams RA, Keller JW, Golomb HM, Steinberg J, Dukart G. Mitoxantrone in malignant lymphomas. Cancer Treat Rev. 1983 Dec; 10 Suppl B:69-72.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|